A decline in bone marrow progenitor B cells driven by oxidative stress actively accelerates the formation of bone-resorbing osteoclasts in an established mouse model of senile osteoporosis, according to research published in the journal Immunity and Ageing. The multi-institutional team demonstrated that the accumulation of reactive oxygen species within the aging femoral niche triggers the activation of the Fos and Jun transcription factor complex within progenitor B lymphocytes. This stress response induces the overexpression and secretion of the chemokine CCL3, which communicates directly with bone marrow macrophages via the chemokine receptor CCR1 to drive osteoclast differentiation and enhance skeletal breakdown. In laboratory cell cultures, pharmacological intervention using the selective CCR1 antagonist compound BX471 effectively mitigated this pro-inflammatory osteoclastogenic cascade, pointing toward an immunomodulatory pathway that could potentially inform therapeutic strategies aimed at mitigating age-related skeletal fragility.
Senile osteoporosis is a widespread skeletal disorder characterized by declining bone mineral density, microarchitectural deterioration, and escalating fracture susceptibility in elderly populations. Although conventional clinical research has historically focused on postmenopausal hormone deficiency or intrinsic dysfunction within osteoblasts and osteoclasts, recent conceptual frameworks emphasizing osteoimmunology highlight the crucial regulatory roles played by immune cells inside the bone microenvironment. Skeletal remodeling requires tightly coordinated cellular dynamics between bone-forming osteoblasts and bone-resorbing osteoclasts derived from the monocyte-macrophage lineage. While standard antiresorptive agents such as bisphosphonates and denosumab reduce resorption, they carry known adverse risks including medication-related osteonecrosis of the jaw. Moreover, natural aging models of osteoporosis frequently present practical experimental challenges, including extended lifespans, substantial animal maintenance costs, and high mortality rates, making the underlying cellular mechanisms linking immune senescence to senile bone loss an essential area of experimental inquiry.
To investigate the cellular interactions governing senile bone loss, the researchers utilized three-month-old male senescence-accelerated mouse prone 6 animals, a validated in vivo model that exhibits accelerated aging and early-onset skeletal deterioration. These were evaluated against age- and sex-matched senescence-accelerated mouse resistant 1 animals, which display normal physiological aging trajectories. Microcomputed tomography imaging of the distal femoral region revealed significant microstructural degradation in the prone strain. Quantitative morphometric analysis demonstrated reductions in trabecular bone volume fraction, trabecular number, trabecular thickness, and cortical bone thickness, alongside increased trabecular separation. Conversely, the overall cortical area fraction showed no statistically significant difference between the two cohorts. Histological assessments via hematoxylin and eosin staining confirmed reduced trabecular architecture, while tartrate-resistant acid phosphatase enzymatic staining demonstrated an elevated frequency of multinucleated osteoclasts displaying three or more nuclei along the distal marrow trabecular surfaces.
Further biochemical profiling revealed marked elevation of oxidative stress and cellular senescence markers throughout the skeletal tissue of the accelerated-aging mice. Flow cytometry using the fluorescent dye 2 prime, 7 prime-dichlorofluorescein diacetate indicated that bone marrow mononuclear cells isolated from the prone mice generated significantly higher baseline levels of intracellular reactive oxygen species compared with resistant controls. Immunohistochemical staining and quantitative real-time polymerase chain reaction assays demonstrated marked upregulation of canonical senescence-associated regulators, specifically p16, p21, and p53, in bone marrow samples. Parallel Western blot and molecular analyses identified heightened protein and transcript levels of key osteoclast-associated enzymes, including cathepsin K, matrix metalloproteinase 9, and tartrate-resistant acid phosphatase. In contrast, essential osteogenic differentiation markers, including runt-related transcription factor 2 and osteocalcin, exhibited substantial declines, confirming an overall imbalance between diminished bone formation and amplified bone resorption.
To resolve which specific cell lineages within the complex bone marrow microenvironment experience age-related perturbations, the authors performed single-cell RNA sequencing on femoral marrow cells from both animal cohorts. Unsupervised cell clustering based on canonical lineage markers segregated the bone marrow population into ten major clusters: B lymphocytes, T lymphocytes, neutrophils, granulocyte-macrophage progenitor cells, dendritic cells, mononuclear phagocytes, hematopoietic stem cells, erythrocytes, erythroid progenitors, and basophils. Single-cell quantification demonstrated a slight but statistically significant drop in total B lymphocyte abundance, falling from 25.6 percent in control mice to 23.4 percent in the prone strain, representing the most prominent proportional decline among all identified lineages. Immunofluorescence staining against the pan-B-cell marker CD19 confirmed this cellular loss in intact histological tissue sections, highlighting adaptive immune alterations within the femoral hematopoietic niche.
Detailed subclustering of the B-lineage cells tracked their developmental ontogeny through four sequential stages: progenitor B cells, precursor B cells, immature B cells, and mature B cells. Flow cytometry gating on CD19, CD45R/B220, and CD43 surface markers demonstrated that progenitor B cells experienced the most pronounced quantitative reduction in prone mice, while precursor B cells decreased slightly and downstream immature and mature B subsets showed moderate relative increases. Pseudotime trajectory reconstructions using Monocle2 revealed a clear developmental divergence during early B-cell ontogeny between the two mouse strains. Functional enrichment analyses through Gene Ontology and Kyoto Encyclopedia of Genes and Genomes databases indicated that differentially expressed genes in prone progenitor B cells were strongly enriched in response pathways to chemical stress, oxidative stress responses, and transcription factor complexes, with marked coordinated upregulation of activator protein-1 family transcription factor genes, including Fos, Fosb, Jun, Junb, and Jund.
Transcriptomic sequencing of fluorescence-activated cell sorted progenitor B cells further revealed an altered secretome characterized by marked chemokine upregulation. Progenitor B cells from prone animals exhibited increased transcript levels of inflammatory chemokines, particularly CCL2 and CCL3. Multiplex cytokine profiling of bone marrow fluid verified a substantial accumulation of secreted CCL3 protein in the prone strain. Cellular crosstalk modeling revealed that the CCL3-CCR1 ligand-receptor pair served as the primary communication bridge connecting perturbed progenitor B cells to neighboring mononuclear phagocyte populations. Intracellular flow cytometry across distinct maturation stages confirmed that elevated CCL3 production originated predominantly from CD19-positive, B220-positive, CD43-positive progenitor B cells rather than downstream immature or mature B lymphocytes. Multicolor immunofluorescence staining of bone marrow sections reinforced these observations, demonstrating high spatial colocalization of elevated c-FOS and CCL3 proteins directly within CD19-expressing B cells.
To establish mechanistic relationships in vitro, the investigators exposed the BaF3 murine pro-B cell line to hydrogen peroxide to model oxidative stress within the bone marrow niche. Treatment with hydrogen peroxide elevated intracellular reactive oxygen species, reduced cell proliferation in CCK-8 viability assays, increased senescence-associated beta-galactosidase staining, and upregulated transcript levels of senescence genes alongside the pro-inflammatory factors interleukin-6, tumor necrosis factor-alpha, and CCL3. Concomitantly, expression of Fos and Jun was significantly enhanced. Dual-luciferase reporter assays confirmed that ectopic overexpression of Fos directly activated the transcription of the Ccl3 promoter construct in BaF3 cells. Subsequent co-culture experiments pairing BaF3 cells with MC3T3-E1 pre-osteoblasts showed that varying B-cell numbers caused minimal impact on osteogenic differentiation or alkaline phosphatase activity, indicating that progenitor B-cell depletion does not directly impair osteoblast matrix mineralizing capacity under these experimental conditions.
In contrast, co-culturing BaF3 cells with RAW 264.7 macrophage precursors revealed a direct regulatory effect on osteoclastogenesis. Lowering the ratio of BaF3 cells from an equal ten-to-ten balance down to a ten-to-one ratio relative to macrophages significantly augmented the formation of tartrate-resistant acid phosphatase-positive multinucleated osteoclasts under receptor activator of nuclear factor kappa-B ligand stimulation. Western blotting demonstrated elevated protein levels of nuclear factor of activated T-cells c1, matrix metalloproteinase 9, c-FOS, cathepsin K, and tartrate-resistant acid phosphatase. Introducing the selective CCR1 antagonist compound BX471 at a concentration of 1 micromolar into the co-culture system effectively abolished this enhanced osteoclast differentiation. Quantitative real-time PCR confirmed that CCR1 inhibition suppressed key osteoclastogenic transcripts as well as inflammatory cytokines like interleukin-6 and tumor necrosis factor-alpha, demonstrating the critical involvement of the CCL3-CCR1 signaling axis in macrophage differentiation.
The therapeutic potential of targeting this pathway was further evaluated using primary bone marrow-derived macrophages isolated directly from prone and control mice. Upon induction with receptor activator of nuclear factor kappa-B ligand, primary macrophages from the prone strain demonstrated significantly greater osteoclast-forming capacity than control cells. Addition of recombinant CCL3 protein amplified osteoclast differentiation in both cohorts, whereas treatment with the CCR1 antagonist BX471 markedly attenuated osteoclast activity and suppressed osteoclastogenic gene expression. Notably, BX471 displayed minimal inhibitory effects on control macrophages, selectively downregulating tartrate-resistant acid phosphatase without substantially altering other markers. The authors noted that the current findings establish strong cellular associations rather than definitive in vivo causality, acknowledging that future work utilizing adoptive progenitor B-cell transfers, conditional genetic deletions, and evaluations of overlapping chemokine receptors will be necessary to fully map immune-skeletal cross-talk during senile osteoporosis.
Subject of Research: Mechanisms linking bone marrow progenitor B cell depletion, oxidative stress, and osteoclastogenesis in senile osteoporosis mouse models
Article Title: Aging-induced decrease in progenitor B cells enhances the osteoclastogenesis of bone marrow macrophages via ROS-activated Fos/CCL3 signaling pathway
Article References: Sun, R., Luo, L., Chen, Y., Sun, L., Huo, Y., Ding, C., & Wang, Y. (2026). Aging-induced decrease in progenitor B cells enhances the osteoclastogenesis of bone marrow macrophages via ROS-activated Fos/CCL3 signaling pathway. Immunity & Ageing, 23(1), Article 12. https://doi.org/10.1186/s12979-026-00561-z
Image Credits: AI Generated
DOI: 10.1186/s12979-026-00561-z
Keywords: senile osteoporosis, progenitor B cells, osteoclastogenesis, reactive oxygen species, SAMP6 mice, SAMR1 mice, CCL3 chemokine, CCR1 receptor, BX471 antagonist, AP-1 transcription complex, c-Fos, bone marrow microenvironment, single-cell RNA sequencing, BaF3 cells, RAW 264.7 macrophages, immunosenescence, bone resorption
Cite Scienmag News
Beatrice Stafford. (November 20, 2026). Declining Progenitor B Cells Accelerate Bone Loss in Aging Mice. Scienmag. https://scienmag.com/declining-progenitor-b-cells-accelerate-bone-loss-in-aging-mice/
Beatrice Stafford. "Declining Progenitor B Cells Accelerate Bone Loss in Aging Mice." Scienmag, 20 November 2026, https://scienmag.com/declining-progenitor-b-cells-accelerate-bone-loss-in-aging-mice/. Accessed 20 November 2026.
Beatrice Stafford. "Declining Progenitor B Cells Accelerate Bone Loss in Aging Mice." Scienmag. November 20, 2026. https://scienmag.com/declining-progenitor-b-cells-accelerate-bone-loss-in-aging-mice/








